Study S001375

Replication of the LEADER Diabetes Trial in Healthcare Claims

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record Study Protocol and Statistical Analysis Plan (PDF)

Registration

Registration: NCT03936049
Study type: OBSERVATIONAL
Status: COMPLETED
Enrollment: 168690
Start: 2017-09-22
Primary completion: 2021-02-18
Lead sponsor: Brigham and Women's Hospital
Conditions: Diabetes
Interventions: DRUG:Liraglutide; DRUG:DPP-4 inhibitor
Results posted: FALSE

Registered primary outcomes

Relative hazard of composite outcome of Stroke, MI, and Mortality [Through study completion (a median of 154-188 days)]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.